Microbiology and Sterility in Pharmaceuticals and Medical Devices - New Book Released with Contribution form Catalent Experts
Somerset, NJ, December 21, 2010 — Andy Martin, a pharmaceutical microbiology expert and Manager of Zydis and Encapsulation Microbiology at Catalent, has joined other top international experts by contributing to a new reference book offering the latest contemporary knowledge on microbiological aspects of sterility assurance for pharmaceuticals.
Published earlier this month, the book entitled “Microbiology and Sterility Assurance in Pharmaceuticals and Medical Devices” is published by Business Horizons and edited by Madhu Raju Saghee, Tim Sandle, and Edward C. Tidswell. Mr. Martin joined the team to contribute his subject matter expertise in a chapter of the book focused on auditing a microlab. His goal was to cover microbiology labs that serve both sterile and non sterile product manufacturing facilities, and provide the reader with insight on the activities that go on in a microlab from the viewpoints of an auditor and from the auditee. Mr. Martin highlighted the common areas that an auditor would focus on during an audit, including media preparation and control, identification of isolates, endotoxin testing and handling of laboratory reference strains.
The book represents an in depth guide in the field of pharmaceutical and medical device microbiology, outlining best practice technical content. The material included in the book is regarded as possible, future and emerging technology or processes.
“I am honored to be a part of the team of contributors for this book, which provides an essential reference guide for today’s pharmaceutical microbiology. At Catalent, we are passionate about innovation and growth and are dedicated to applying our expertise to improve the industry” said Andy Martin.
Andy has 25 years experience in the pharmaceutical industry and has managed microbiology laboratories for almost half of this time. He has specialized expertise in the area of microbiological quality control and quality assurance for both sterile and non-sterile products and is also Treasurer for the UK microbiology interest group, Pharmig.
For more information regarding “Microbiology and Sterility Assurance in Pharmaceuticals and Medical Devices”, visit www.businesshorizons.com.
Headquartered in Somerset, New Jersey, Catalent is a leading provider of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 at 29 facilities worldwide and in fiscal 2010 generated more than $1.7 billion of annual revenue. For more information, visit www.catalent.com.
more products. better treatments. reliably supplied.™
T (732) 537-6407